OPEN as of November 1, 2026. The Foundation's October 7, 2026 announcement confirms applications opened October 1, 2026 and close January 22, 2027. One-year awards expected to start July 1, 2027.
Verified 2026-11-01
The Charlie Landers Foundation
2027 pediatric Ewing sarcoma research grants of $20,000–$150,000 for one year, administered through U.S. nonprofit institutions. MD/PhD investigators may apply by January 22, 2027. Preclinical, translational and clinical research; no indirect costs; optional second year subject to approval.
Required next actionReview complete 2027 application instructions at https://www.thecharlielandersfoundation.org/2027-grant-application, compile cover page, NIH biosketches, lay/scientific abstract, four-page research plan, one-page budget and justification, other funding disclosure and collaborator letters into one PDF, and submit via that page's application form by January 22, 2027. Confirm the precise submission cutoff with the funder.
OPEN as of November 1, 2026. The Foundation confirms the 2027 Young Investigator funding cycle opened October 1, 2026 and closes December 11, 2026.
Verified 2026-11-01
The Charlie Landers Foundation
2027 Young Investigator Award for pediatric Ewing sarcoma research: $50,000 for one year, deadline December 11, 2026. Qualified early-career MD/PhD researchers need a pediatric oncology mentor, 75% protected research time and an eligible nonprofit host institution.
Required next actionRead the official 2027 Young Investigator instructions at https://www.thecharlielandersfoundation.org/young-investigators-grant-application. Verify 5-year fellowship, 75% protected time, mentor and NIH award eligibility; prepare one PDF with cover, NIH biosketches, one-page abstract, four-page research plan, career development and mentoring plan, separate mentor letter, one-page budget and collaborator letters. Submit through the page form by December 11, 2026 and confirm the exact closing time with the Foundation.